The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Regeneron Pharmaceuticals, Inc. shares valued at $241,182 were sold by McCourt Marion on Apr 01 ’24. At $964.73 per share, McCourt Marion sold 250 shares. The insider’s holdings dropped to 13,181 shares worth approximately $11.74 million following the completion of this transaction.
Also, RYAN ARTHUR F sold 100 shares, netting a total of over 96,253 in proceeds. Following the sale of shares at $962.53 each, the insider now holds 18,182 shares.
Before that, MURPHY ANDREW J had sold 5,783 shares from its account. In a trade valued at $5,531,290, the EVP Research traded Regeneron Pharmaceuticals, Inc. shares for $956.47 each. Upon closing the transaction, the insider’s holdings decreased to 5,783 shares, worth approximately $43.03 million.
As published in their initiating research note from Bernstein on March 12, 2024, Regeneron Pharmaceuticals, Inc. [REGN] has been an Outperform and the price target has been revised to $1125. Analysts at RBC Capital Mkts upgraded the stock from ‘”a Sector perform”‘ to ‘”an Outperform”‘ outlook in a report released in mid January. As of November 09, 2023, Deutsche Bank has initiated its “Hold” rating for REGN. Earlier on November 03, 2023, Raymond James upgraded its rating. Their new recommendation was “an Outperform” for REGN stock which previously was a “a Mkt perform”.
Analyzing REGN Stock Performance
During the last five days, there has been a drop of approximately -0.37%. Over the course of the year, Regeneron Pharmaceuticals, Inc. shares have jumped approximately 1.41%. Shares of the company reached a 52-week high of $998.33 on 02/28/24 and a 52-week low of $871.39 on 01/02/24. A 50-day SMA is recorded $949.14, while a 200-day SMA reached $863.16. Nevertheless, trading volume fell to 0.58 million shares from 0.34 million shares the previous day.
Support And Resistance Levels for Regeneron Pharmaceuticals, Inc. (REGN)
According to the 24-hour chart, there is a support level at 873.29, which, if violated, would cause prices to drop to 855.89. In the upper region, resistance lies at 911.54. The next price resistance is at 932.39. RSI (Relative Strength Index) is 31.27 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -7.99, which suggests the price will decrease in the coming days. Percent R is at 80.77%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
